R. Pasquali et al., THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN OBESE WOMEN WITH DIFFERENTPATTERNS OF BODY-FAT DISTRIBUTION, The Journal of clinical endocrinology and metabolism, 77(2), 1993, pp. 341-346
To investigate whether obese subjects with abdominal obesity may be ch
aracterized by hyperactivity of the hypothalamic-pituitary-adrenal axi
s, we examined two groups of obese women with a waist to hip ratio (WH
R) lower than 0.80 (n = 13), therefore having peripheral body fat dist
ribution (P-BFD), or a WHR higher than 0.85 (n = 12), thus having abdo
minal body fat distribution (A-BFD). A group of seven normal weight he
althy women served as controls. All subjects underwent the following p
rotocol study that included 1) measurement of daily urinary free corti
sol excretion rate; 2) a CRF test (human CRF, 1 mug/kg BW, as iv bolus
), with blood samples taken at regular intervals for ACTH and cortisol
determination; and 3) an ACTH test, performed by administering two bo
li of ACTH (Synacthen, 0.2 mug/kg BW, iv), at 90-min intervals, with b
lood samples taken for cortisol determination. Each woman also had a c
ontrol saline study. Basal levels of both ACTH and cortisol rose signi
ficantly after CRF administration in all groups, but this increase was
significantly higher in A-BFD than in P-BFD and control women. A sign
ificant correlation was found between the incremental area of cortisol
and that of ACTH during the CRF test (r = 0.502), but not between the
se parameters and WHR values. Although the cortisol increase after the
ACTH test was higher in A-BFD than in the other groups, these differe
nces were only significant at 60 min during the test and when the anal
ysis for repeated measures was applied. On the contrary, the increment
al cortisol area after the ACTH test was not significantly different i
n the three groups. Moreover, it was not significantly correlated with
the incremental cortisol area after CRF test or WHR values. Daily uri
nary free cortisol excretion rates (per g creatinine), however, were s
ignificantly higher in A-BFD than in P-BFD and control women. These re
sults, therefore, suggest that obese women with A-BFD may have hyperac
tivity of the hypothalamic-pituitary-adrenal axis. This abnormality co
uld be central in origin, due to hypersecretion of CRF or ACTH; altern
atively, it could represent an adaptive phenomenon secondary to a stat
e of functional cortisol resistance.